Aspeya
Kim Binderup is a seasoned professional in the fields of consumer health and nutrition, currently serving as Chief Consumer Health Officer at Aspeya since 2022. Simultaneously, Kim holds the position of Vice President of Consumer- and Digital Health at Philip Morris International and serves as a Board Member for Beo Therapeutics AG. With prior experience as Global Vice President of Innovation for DSM's Human Nutrition & Health division from 2016 to 2021, Kim led innovation initiatives for a significant business sector. Kim has also held various leadership roles at Chr. Hansen in product development and innovation across different divisions, including Human Health and Natural Colors. Earlier career milestones include consulting at Boston Consulting Group and serving as a Fermentation Scientist at DSM Anti-Infectives. Kim’s academic credentials include an Executive MBA from London Business School and a PhD in Biochemistry from Michigan State University.
This person is not in any teams
This person is not in any offices
Aspeya
We are on a journey to empower healthier lifestyles and target specific unmet needs. We do this by being innovative, optimizing formulas, and applying rigorous scientific standards. This involves harnessing deep insight and scientific substantiation to reimagine how ingredients can be used, and working towards the development and commercialization of a pipeline of wellness and healthcare products and brands. We are applying our expertise to innovate in four areas of focus: Consumer health, cannabinoids, inhaled therapeutics, and nicotine replacement therapy. Our people are open-minded thinkers, leading-edge scientists, and knowledgeable innovators. Want to join our team? Visit our careers site to search for opportunities: careers.aspeya.com